Experiences of Participation in a Multimodal Preventive Trial MIND-AD_MINI Among Persons with Prodromal Alzheimer’s Disease: A Qualitative Study

References

• Apostolova LG. Alzheimer Disease. Continuum (Minneap Minn). 2016;22(2Dementia):419–434.
   PubMedGoogle Scholar
• World Health Organization. Dementia: A Public Health Priority. Geneva, Switzerland: World Health Organization; 2012. Retrieved from: https://www.who.int/publications/i/item/dementia-a-public-health-priority. Accessed December 30, 2021.
   Google Scholar
• Gauthier S, Albert M, Fox N, et al. Why has therapy development for dementia failed in the last two decades? Alzheimer’sdementia. 2016;12(1):60–64.
   PubMed Web of Science ®Google Scholar
• Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10:819–828.
   PubMed Web of Science ®Google Scholar
• Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–2734.
   PubMed Web of Science ®Google Scholar
• Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–2263.
   PubMed Web of Science ®Google Scholar
• Andrieu S, Guyonnet S, Coley N, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017;16(5):377–389.
   PubMed Web of Science ®Google Scholar
• Chhetri JK, de Souto Barreto P, Cantet C, et al. Effects of a 3-Year multi-domain intervention with or without omega-3 supplementation on cognitive functions in older subjects with increased CAIDE dementia scores. J Alzheimers Dis. 2018;64(1):71–78.
   PubMed Web of Science ®Google Scholar
• Moll van Charante EP, Richard E, Eurelings LS, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet. 2016;388(10046):797–805.
   PubMed Web of Science ®Google Scholar
• Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer’s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64(5):492–498.
   PubMed Web of Science ®Google Scholar
• Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–629.
   PubMed Web of Science ®Google Scholar
• Donohue MC, Sperling RA, Salmon DP, et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014;71(8):961–970.
   PubMed Web of Science ®Google Scholar
• Sperling RA, Jack CR Jr., Aisen PS. Testing the right target and right drug at the right stage. Sci Transl Med. 2011;3(111):111cm133.
   Web of Science ®Google Scholar
• Aisen PS, Andrieu S, Sampaio C, et al. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011;76(3):280–286.
   PubMed Web of Science ®Google Scholar
• Sindi S, Thunborg C, Rosenberg A, et al. Multimodal preventive trial for Alzheimer’s Disease: MIND-ADMINI Pilot Trial Study Design and Progress. J Prev Alzheimer’s Dis. 2022:1-10.
   PubMed Web of Science ®Google Scholar
• Vellas B, Pesce A, Robert PH, et al. AMPA workshop on challenges faced by investigators conducting Alzheimer’s disease clinical trials. Alzheimer’sdementia. 2011;7(4):e109–117.
   PubMedGoogle Scholar
• Dellson P, Nilsson K, Jernström H, Carlsson C. Patients’ reasoning regarding the decision to participate in clinical cancer trials: an interview study. Trials. 2018;19(1):528.
   PubMed Web of Science ®Google Scholar
• Grill JD, Galvin JE. Facilitating Alzheimer disease research recruitment. Alzheimer Dis Assoc Disord. 2014;28(1):1–8.
   PubMed Web of Science ®Google Scholar
• Grill JD, Karlawish J, Elashoff D, Vickrey BG. Risk disclosure and preclinical Alzheimer’s disease clinical trial enrollment. Alzheimer’s Dementia. 2013;9(3):356–359.e351.
   PubMed Web of Science ®Google Scholar
• Kvale S. Interviews: An Introduction to Qualitative Research Interviewing. Lund: Studentlitteratur; 2007.
   Google Scholar
• Whiting LS. Semi-structured interviews: guidance for novice researchers. Nurs Stand. 2008;22(23):35–40.
   PubMedGoogle Scholar
• Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105–112.
   PubMed Web of Science ®Google Scholar
• Graneheim UH, Lindgren BM, Lundman B. Methodological challenges in qualitative content analysis: a discussion paper. Nurse Educ Today. 2017;56:29–34.
   PubMed Web of Science ®Google Scholar
• Nuno MM, Gillen DL, Dosanjh KK, et al. Attitudes toward clinical trials across the Alzheimer’s disease spectrum. Alzheimers Res Ther. 2017;9(1):81.
   PubMed Web of Science ®Google Scholar
• Solomon A, Akenine U, Andreasen N, et al. Practical lessons from amyloid immunotherapy trials in Alzheimer disease. Curr Alzheimer Res. 2012;9(10):1126–1134.
   PubMed Web of Science ®Google Scholar
• Cahill S, Pierce M, Werner P, Darley A, Bobersky A. A systematic review of the public’s knowledge and understanding of Alzheimer’s disease and dementia. Alzheimer Dis Assoc Disord. 2015;29(3):255–275.
   PubMed Web of Science ®Google Scholar
• Kim S, Sargent-Cox KA, Anstey KJ. A qualitative study of older and middle-aged adults’ perception and attitudes towards dementia and dementia risk reduction. J Adv Nurs. 2015;71(7):1694–1703.
   PubMed Web of Science ®Google Scholar
• Glynn RW, Shelley E, Lawlor BA. Public knowledge and understanding of dementia-evidence from a national survey in Ireland. Age Ageing. 2017;46(5):865–869.
   PubMed Web of Science ®Google Scholar
• Coley N, Rosenberg A, van Middelaar T, et al. Older Adults’ reasons for participating in an eHealth prevention trial: a cross-country, mixed-methods comparison. J Am Med Dir Assoc. 2019;20(7):843–849.
   PubMed Web of Science ®Google Scholar
• Rosenberg A, Coley N, Soulier A, et al. Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial. BMC Geriatr. 2020;20(1):99.
   PubMed Web of Science ®Google Scholar
• Bardach SH, Parsons K, Gibson A, Jicha GA. “From victimhood to warriors”: super-researchers’ insights into Alzheimer’s disease clinical trial participation motivations. The Gerontologist. 2020;60(4):693–703.
   PubMed Web of Science ®Google Scholar
• Robinson L, Gemski A, Abley C, et al. The transition to dementia–individual and family experiences of receiving a diagnosis: a review. Int Psychogeriatrics. 2011;23(7):1026–1043.
   PubMed Web of Science ®Google Scholar
• Morris JL, Hu L, Hunsaker A, Liptak A, Seaman JB, Lingler JH. Patients’ and Family members’ subjective experiences of a diagnostic evaluation of mild cognitive impairment. J Patient Exp. 2020;7(1):124–131.
   PubMedGoogle Scholar
• Hedman R, Hellström I, Ternestedt BM, Hansebo G, Norberg A. Sense of self in Alzheimer’s research participants. Clin Nurs Res. 2018;27(2):191–212.
   PubMed Web of Science ®Google Scholar
• Black BS, Taylor H, Rabins PV, Karlawish J. Researchers’ perspectives on the role of study partners in dementia research. Int Psychogeriatrics. 2014;26(10):1649–1657.
   PubMed Web of Science ®Google Scholar
• Black BS, Taylor HA, Rabins PV, Karlawish J. Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role. Dementia (London, England). 2016;17(4):494.
   Google Scholar
• Bardach SH, Holmes SD, Jicha GA. Motivators for Alzheimer’s disease clinical trial participation. Aging Clin Exp Res. 2018;30(2):209–212.
   PubMed Web of Science ®Google Scholar
• Grill JD, Kwon J, Teylan MA, et al. Retention of Alzheimer disease research participants. Alzheimer Dis Assoc Disord. 2019;33(4):299–306.
   PubMed Web of Science ®Google Scholar
• Clement C, Selman LE, Kehoe PG, Howden B, Lane JA, Horwood J. Challenges to and Facilitators of Recruitment to an Alzheimer’s Disease Clinical Trial: a Qualitative Interview Study. J Alzheimer’s Dis. 2019;69(4):1067–1075.
   PubMed Web of Science ®Google Scholar
• Turunen M, Hokkanen L, Bäckman L, et al. Computer-based cognitive training for older adults: determinants of adherence. PLoS One. 2019;14(7):e0219541.
   PubMed Web of Science ®Google Scholar
• McGrattan AM, McEvoy CT, Vijayakumar A, et al. A mixed methods pilot randomised controlled trial to develop and evaluate the feasibility of a Mediterranean diet and lifestyle education intervention ‘THINK-MED’ among people with cognitive impairment. Pilot Feasibility Stud. 2021;7(1):3.
   PubMedGoogle Scholar
• Milne R, Bunnik E, Tromp K, et al. Ethical issues in the development of readiness cohorts in Alzheimer’s disease research. j Prev Alzheimer’s Dis. 2017;4(2):125–131.
   PubMed Web of Science ®Google Scholar
• Milne R, Diaz A, Badger S, Bunnik E, Fauria K, Wells K. At, with and beyond risk: expectations of living with the possibility of future dementia. Sociol Health Illn. 2018;40(6):969–987.
   PubMed Web of Science ®Google Scholar
• Akenine U, Barbera M, Beishuizen CR, et al. Attitudes of at-risk older adults about prevention of cardiovascular disease and dementia using eHealth: a qualitative study in a European context. BMJ Open. 2020;10(8):e037050.
   PubMed Web of Science ®Google Scholar
• Beishuizen CR, Akenine U, Barbera M, et al. Integrating nurses’ experiences with supporting behaviour change for cardiovascular prevention into a self-management internet platform in Finland and the Netherlands: a qualitative study. BMJ Open. 2019;9(6):e023480.
   PubMed Web of Science ®Google Scholar